136 related articles for article (PubMed ID: 35792131)
1. MTA1: A Vital Modulator in Prostate Cancer.
Ma J; Li C; Qian H; Zhang Y
Curr Protein Pept Sci; 2022; 23(7):456-464. PubMed ID: 35792131
[TBL] [Abstract][Full Text] [Related]
2. The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications.
Toh Y; Nicolson GL
Clin Exp Metastasis; 2009; 26(3):215-27. PubMed ID: 19116762
[TBL] [Abstract][Full Text] [Related]
3. Targeting MTA1/HIF-1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression.
Butt NA; Kumar A; Dhar S; Rimando AM; Akhtar I; Hancock JC; Lage JM; Pound CR; Lewin JR; Gomez CR; Levenson AS
Cancer Med; 2017 Nov; 6(11):2673-2685. PubMed ID: 29024573
[TBL] [Abstract][Full Text] [Related]
4. Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer.
Li K; Dias SJ; Rimando AM; Dhar S; Mizuno CS; Penman AD; Lewin JR; Levenson AS
PLoS One; 2013; 8(3):e57542. PubMed ID: 23469203
[TBL] [Abstract][Full Text] [Related]
5. Role of MTA1 in cancer progression and metastasis.
Sen N; Gui B; Kumar R
Cancer Metastasis Rev; 2014 Dec; 33(4):879-89. PubMed ID: 25344802
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex.
Kai L; Samuel SK; Levenson AS
Int J Cancer; 2010 Apr; 126(7):1538-48. PubMed ID: 19810103
[TBL] [Abstract][Full Text] [Related]
7. MTA1 drives malignant progression and bone metastasis in prostate cancer.
Kumar A; Dhar S; Campanelli G; Butt NA; Schallheim JM; Gomez CR; Levenson AS
Mol Oncol; 2018 Sep; 12(9):1596-1607. PubMed ID: 30027683
[TBL] [Abstract][Full Text] [Related]
8. Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1).
Kai L; Wang J; Ivanovic M; Chung YT; Laskin WB; Schulze-Hoepfner F; Mirochnik Y; Satcher RL; Levenson AS
Prostate; 2011 Feb; 71(3):268-80. PubMed ID: 20717904
[TBL] [Abstract][Full Text] [Related]
9. Nuclear MTA1 overexpression is associated with aggressive prostate cancer, recurrence and metastasis in African Americans.
Dias SJ; Zhou X; Ivanovic M; Gailey MP; Dhar S; Zhang L; He Z; Penman AD; Vijayakumar S; Levenson AS
Sci Rep; 2013; 3():2331. PubMed ID: 23900262
[TBL] [Abstract][Full Text] [Related]
10. Metastasis-associated protein 1 drives tumor cell migration and invasion through transcriptional repression of RING finger protein 144A.
Marzook H; Li DQ; Nair VS; Mudvari P; Reddy SD; Pakala SB; Santhoshkumar TR; Pillai MR; Kumar R
J Biol Chem; 2012 Feb; 287(8):5615-26. PubMed ID: 22184113
[TBL] [Abstract][Full Text] [Related]
11. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
12. Properties and clinical relevance of MTA1 protein in human cancer.
Toh Y; Nicolson GL
Cancer Metastasis Rev; 2014 Dec; 33(4):891-900. PubMed ID: 25359582
[TBL] [Abstract][Full Text] [Related]
13. MTA family of proteins in prostate cancer: biology, significance, and therapeutic opportunities.
Levenson AS; Kumar A; Zhang X
Cancer Metastasis Rev; 2014 Dec; 33(4):929-42. PubMed ID: 25332143
[TBL] [Abstract][Full Text] [Related]
14. Repression of NR4A1 by a chromatin modifier promotes docetaxel resistance in PC-3 human prostate cancer cells.
Yu L; Su YS; Zhao J; Wang H; Li W
FEBS Lett; 2013 Aug; 587(16):2542-51. PubMed ID: 23831020
[TBL] [Abstract][Full Text] [Related]
15. MTA1 expression in human cancers - Clinical and pharmacological significance.
Malisetty VL; Penugurti V; Panta P; Chitta SK; Manavathi B
Biomed Pharmacother; 2017 Nov; 95():956-964. PubMed ID: 28915537
[TBL] [Abstract][Full Text] [Related]
16. MTA-1 expression is associated with metastasis and epithelial to mesenchymal transition in colorectal cancer cells.
Tuncay Cagatay S; Cimen I; Savas B; Banerjee S
Tumour Biol; 2013 Apr; 34(2):1189-204. PubMed ID: 23371285
[TBL] [Abstract][Full Text] [Related]
17. Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer.
Li DQ; Pakala SB; Nair SS; Eswaran J; Kumar R
Cancer Res; 2012 Jan; 72(2):387-94. PubMed ID: 22253283
[TBL] [Abstract][Full Text] [Related]
18. MTA1-mediated transcriptional repression of BRCA1 tumor suppressor gene.
Molli PR; Singh RR; Lee SW; Kumar R
Oncogene; 2008 Mar; 27(14):1971-80. PubMed ID: 17922032
[TBL] [Abstract][Full Text] [Related]
19. Metastasis-associated protein 1: A potential driver and regulator of the hallmarks of cancer.
Vattem C; Pakala SB
J Biosci; 2022; 47():. PubMed ID: 36210748
[TBL] [Abstract][Full Text] [Related]
20. MTA1-Dependent Anticancer Activity of Gnetin C in Prostate Cancer.
Kumar A; Dholakia K; Sikorska G; Martinez LA; Levenson AS
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31487842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
